Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders

Synopsis

Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.